Deepthi Suresh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Deepthi Suresh has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Alka Khadwal
Department of Clinical Hematology and Medical Oncology Postgraduate Institute of Medical Education and Research Chandigarh India
1 shared publication - Amanjit Bal
PGIMER
1 shared publication - Arihant Jain
Department of Clinical Hematology and Medical Oncology, PGIMER, Chandigarh, India
1 shared publication - Deepesh Lad
Post Graduate Institute of Medical Education and Research, Chandigarh, India
1 shared publication - Pankaj Malhotra
Department of Clinical Hematology and Medical Oncology Postgraduate Institute of Medical Education and Research Chandigarh India
1 shared publication - Pulkit Rastogi
Department of Hematology, Postgraduate Institute of Medical Education and Research, Chandigarh, India
1 shared publication
Latest Publications
- 1 July 2024
- Published by Taylor & Francis in Leukemia & Lymphoma
- Vol. 65 (11) , 1675-1690
Bridging the gap: understanding contemporary autopsies in acute leukemia by comparing ante-mortem and post-mortem profiles
This study investigates acute myeloid leukemia/lymphoblastic leukemia (AML/ALL) through a 14-year analysis (2009-2022) of 46 autopsied cases (age >12 years). B-ALL was the dominant subtype (34.8%). Liver and spleen were the common sites of active leukemia (63% cases). Symptoms like dyspnea and altered sensorium associated significantly with heart (p = .031) and brain leukostasis (p = .006). Measurable residual disease (MRD) negativity correlated with disease-free status outside the bone marrow, while MRD-positive cases displayed leukemic infiltrates. Infections were identified in 23 autopsied cases, notably linked to post-induction and post-transplant fatalities. Surprisingly, 18 of these 23 cases had unexpected infections mainly fungal (13 cases) with Aspergillus species as the most common. Diagnostic discrepancies were identified in 48% of cases. Malignant infiltration (46%) and infections (25%) were the leading causes of death. This research sheds light on leukemia in extra-medullary tissues, uncovers novel clinical-pathological associations, and highlights overlooked therapy side effects, offering insights for future case management.
- 1 July 2024
- Published by Taylor & Francis in Leukemia & Lymphoma
- Vol. 65 (11) , 1675-1690
Bridging the gap: understanding contemporary autopsies in acute leukemia by comparing ante-mortem and post-mortem profiles
This study investigates acute myeloid leukemia/lymphoblastic leukemia (AML/ALL) through a 14-year analysis (2009-2022) of 46 autopsied cases (age >12 years). B-ALL was the dominant subtype (34.8%). Liver and spleen were the common sites of active leukemia (63% cases). Symptoms like dyspnea and altered sensorium associated significantly with heart (p = .031) and brain leukostasis (p = .006). Measurable residual disease (MRD) negativity correlated with disease-free status outside the bone marrow, while MRD-positive cases displayed leukemic infiltrates. Infections were identified in 23 autopsied cases, notably linked to post-induction and post-transplant fatalities. Surprisingly, 18 of these 23 cases had unexpected infections mainly fungal (13 cases) with Aspergillus species as the most common. Diagnostic discrepancies were identified in 48% of cases. Malignant infiltration (46%) and infections (25%) were the leading causes of death. This research sheds light on leukemia in extra-medullary tissues, uncovers novel clinical-pathological associations, and highlights overlooked therapy side effects, offering insights for future case management.